価格表

在庫・価格 : 2024年05月16日 09時40分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
ADAM10, Human, Recombinant, Carrier-free
データシート
936-AD-020 RSDアールアンドディー システムス
R&D Systems, Inc.
20 μg ¥125,000
(未発注)
追加

在庫・価格 : 2024年05月16日 09時40分 現在

ADAM10, Human, Recombinant, Carrier-free

  • 商品コード:936-AD-020
  • メーカー:RSD
  • 包装:20μg
  • 価格: ¥125,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hinkle CL et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 2004 Jun;279(23):24179-
Hinkle CL et al
2004/01/01
Application: Enzyme Activity, Sample Type: recombinant protein PubMed
2 Schulte M et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 2007 May;14(5):1040-9
Schulte M et al
2007/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Fridman JS et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007 Mar;13(6):1892-902
Fridman JS et al
2007/01/01
Application: Bioassay, Sample Type: Peptide Substrate PubMed
4 Lemieux GA et al. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 2007 May;282(20):14836-44
Lemieux GA et al
2007/01/01
Application: Enzyme Activity, Sample type: D10 affinity-matured variant of hVbeta2 PubMed
5 Moss ML et al. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 2007 Dec;282(49):35712-21
Moss ML et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: recombinant protein PubMed
6 Rapti M et al. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Biochem. J. 2008 Apr;411(2):433-9
Rapti M et al
2008/01/01
Application: Bioassay PubMed
7 Kohga K et al. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res. 2009 Oct;69(20):8050-7
Kohga K et al
2009/01/01
Application: Media Supplement - Cell Prep, Sample Type: Whole Tissue PubMed
8 Hayes CD et al. Striking reduction of amyloid plaque burden in an Alzheimer"s mouse model after chronic administration of carmustine. BMC Med 2013;11:81
Hayes CD et al
2013/01/01
Application: inhibition, Sample Type: Whole Cells PubMed
9 McDonald AJ et al. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein. J. Biol. Chem. 2014 Jan;289(2):803-13
McDonald AJ et al
2014/01/01
Application: Enzyme Activity, Sample Type: Cell Lysates PubMed
10 Lajoie L et al. ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation. J. Immunol. 2014 Jan;192(2):741-51
Lajoie L et al
2014/01/01
Application: Bioassay, Sample Type: recombinant protein PubMed
11 Schlomann U et al. ADAM8 as a drug target in pancreatic cancer. Nat Commun 2015;6:6175
Schlomann U et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Kl淡verpris S et al. Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A. J. Biol. Chem. 2015 Sep;290(36):21915-24
Kl淡verpris S et al
2015/01/01
Application: Enzyme Assay, Sample Type: Proteins PubMed
13 テ〕varez-Fernテ。ndez SM et al. Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients. Oncotarget 2016 Nov;7(48):80059-80076
テ〕varez-Fernテ。ndez SM et al
2016/01/01
Application: Enzyme Activity, Sample Type: Serum PubMed
14 Parra LM et al. Growth factor and co-receptor release by structural regulation of substrate metalloprotease accessibility. Sci Rep 2016 Nov;6:37464
Parra LM et al
2016/01/01
Application: Enzyme Assay, Sample Type: Proteins PubMed
15 Wong E et al. Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo. Sci Rep 2016 Dec;6:35598
Wong E et al
2016/01/01
Application: Enzyme Assay, Sample Type: Proteins PubMed
16 Conant K et al. Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation. J Neuroinflammation 2017 Mar;14(1):56
Conant K et al
2017/01/01
Application: Bioassay, Sample Type: recombinant protein PubMed
  • No.: 1
  • 文献情報:
    Hinkle CL et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 2004 Jun;279(23):24179-
    Hinkle CL et al
    2004/01/01
  • 備考:
    Application: Enzyme Activity, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Schulte M et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 2007 May;14(5):1040-9
    Schulte M et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Fridman JS et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007 Mar;13(6):1892-902
    Fridman JS et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Peptide Substrate
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Lemieux GA et al. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 2007 May;282(20):14836-44
    Lemieux GA et al
    2007/01/01
  • 備考:
    Application: Enzyme Activity, Sample type: D10 affinity-matured variant of hVbeta2
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Moss ML et al. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 2007 Dec;282(49):35712-21
    Moss ML et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: recombinant protein
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Rapti M et al. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Biochem. J. 2008 Apr;411(2):433-9
    Rapti M et al
    2008/01/01
  • 備考:
    Application: Bioassay
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kohga K et al. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res. 2009 Oct;69(20):8050-7
    Kohga K et al
    2009/01/01
  • 備考:
    Application: Media Supplement - Cell Prep, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hayes CD et al. Striking reduction of amyloid plaque burden in an Alzheimer"s mouse model after chronic administration of carmustine. BMC Med 2013;11:81
    Hayes CD et al
    2013/01/01
  • 備考:
    Application: inhibition, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    McDonald AJ et al. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein. J. Biol. Chem. 2014 Jan;289(2):803-13
    McDonald AJ et al
    2014/01/01
  • 備考:
    Application: Enzyme Activity, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Lajoie L et al. ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation. J. Immunol. 2014 Jan;192(2):741-51
    Lajoie L et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Schlomann U et al. ADAM8 as a drug target in pancreatic cancer. Nat Commun 2015;6:6175
    Schlomann U et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Kl淡verpris S et al. Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A. J. Biol. Chem. 2015 Sep;290(36):21915-24
    Kl淡verpris S et al
    2015/01/01
  • 備考:
    Application: Enzyme Assay, Sample Type: Proteins
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    テ〕varez-Fernテ。ndez SM et al. Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients. Oncotarget 2016 Nov;7(48):80059-80076
    テ〕varez-Fernテ。ndez SM et al
    2016/01/01
  • 備考:
    Application: Enzyme Activity, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Parra LM et al. Growth factor and co-receptor release by structural regulation of substrate metalloprotease accessibility. Sci Rep 2016 Nov;6:37464
    Parra LM et al
    2016/01/01
  • 備考:
    Application: Enzyme Assay, Sample Type: Proteins
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Wong E et al. Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo. Sci Rep 2016 Dec;6:35598
    Wong E et al
    2016/01/01
  • 備考:
    Application: Enzyme Assay, Sample Type: Proteins
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Conant K et al. Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation. J Neuroinflammation 2017 Mar;14(1):56
    Conant K et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: recombinant protein
  • 参照:
    PubMed